John Dillon

19.5k total citations · 4 hit papers
373 papers, 10.4k citations indexed

About

John Dillon is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, John Dillon has authored 373 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 196 papers in Epidemiology, 194 papers in Hepatology and 45 papers in Surgery. Recurrent topics in John Dillon's work include Liver Disease Diagnosis and Treatment (143 papers), Hepatitis C virus research (134 papers) and Liver Disease and Transplantation (76 papers). John Dillon is often cited by papers focused on Liver Disease Diagnosis and Treatment (143 papers), Hepatitis C virus research (134 papers) and Liver Disease and Transplantation (76 papers). John Dillon collaborates with scholars based in United Kingdom, United States and Canada. John Dillon's co-authors include Sandra Macfarlane, Peter Hayes, Sharon Hutchinson, David Goldberg, Michael H. Miller, Peter T. Donnan, Paul Brennan, David J. McLernon, Matthew Hickman and John D. Hayes and has published in prestigious journals such as The Lancet, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

John Dillon

354 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

2009 732 citations John Dillon et al. profile →
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

2013 368 citations Natasha K. Martin, Jason Grebely et al. Hepatology profile →
Guidelines on the management of abnormal liver blood tests

2017 340 citations John Dillon, Andrew D. Yeoman et al. Gut profile →
Development and Validation of a Deep-Learning Model to Screen for Hyperkalemia From the Electrocardiogram

2019 209 citations John Dillon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Dillon United Kingdom	49	4.8k	4.2k	1.5k	1.3k	1.2k	373	10.4k
George N. Ioannou United States	59	8.0k 1.7×	5.6k 1.3×	2.1k 1.4×	2.0k 1.5×	318 0.3×	211	12.6k
Paul J. Thuluvath United States	64	6.0k 1.3×	7.8k 1.9×	5.3k 3.5×	800 0.6×	349 0.3×	295	12.1k
John O’Grady United Kingdom	45	3.5k 0.7×	4.2k 1.0×	2.6k 1.7×	876 0.7×	217 0.2×	200	8.2k
Peter Hayes United Kingdom	63	7.8k 1.6×	9.1k 2.2×	5.2k 3.5×	1.3k 0.9×	386 0.3×	431	14.4k
Frederik Nevens Belgium	62	7.8k 1.6×	9.2k 2.2×	5.6k 3.7×	2.0k 1.5×	321 0.3×	435	15.4k
Joseph K. Lim United States	49	5.6k 1.2×	4.5k 1.1×	1.8k 1.2×	524 0.4×	181 0.1×	211	9.0k
François Durand France	64	9.8k 2.0×	12.8k 3.0×	7.3k 4.9×	1.1k 0.8×	1.2k 0.9×	368	17.7k
William Bernal United Kingdom	48	4.4k 0.9×	6.2k 1.5×	2.4k 1.6×	701 0.5×	388 0.3×	184	10.3k
Frank Lammert Germany	65	6.6k 1.4×	5.3k 1.3×	5.4k 3.6×	1.9k 1.4×	211 0.2×	514	15.3k
Don C. Rockey United States	72	8.3k 1.7×	8.8k 2.1×	6.0k 4.0×	2.7k 2.0×	407 0.3×	462	20.0k

Countries citing papers authored by John Dillon

Since Specialization

Citations

This map shows the geographic impact of John Dillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Dillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Dillon more than expected).

Fields of papers citing papers by John Dillon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Dillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Dillon. The network helps show where John Dillon may publish in the future.

Co-authorship network of co-authors of John Dillon

This figure shows the co-authorship network connecting the top 25 collaborators of John Dillon. A scholar is included among the top collaborators of John Dillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Dillon. John Dillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Radley, Andrew, et al.. (2025). Future destinations: how people cured of hepatitis C using direct acting antiviral drugs progress in a new HCV-free world. A thematic analysis. Harm Reduction Journal. 22(1). 10–10.

Dillon, John, et al.. (2024). Intelligent Liver Function Testing (iLFT): An Intelligent Laboratory Approach to Identifying Chronic Liver Disease. Diagnostics. 14(9). 960–960. 2 indexed citations

Brennan, Paul, Wenhao Li, Thomas Marjot, et al.. (2024). Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice. The Lancet. Gastroenterology & hepatology. 9(6). 577–582. 10 indexed citations

Ivancovsky‐Wajcman, Dana, Christopher J. Byrne, John Dillon, et al.. (2024). A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver disease. Hepatology. 6 indexed citations

Innes, Hamish, Philip J. Johnson, Scott McDonald, et al.. (2022). Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-making. SHILAP Revista de lepidopterología. 1(2). 129–136. 3 indexed citations

Lazarus, Jeffrey V., Henry E. Mark, Massimo Colombo, et al.. (2021). A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach. Alimentary Pharmacology & Therapeutics. 55(2). 234–243. 8 indexed citations

Thongprayoon, Charat, Mira T. Keddis, Andrea G. Kattah, et al.. (2021). Machine Learning Consensus Clustering Approach for Hospitalized Patients with Dysmagnesemia. Diagnostics. 11(11). 2119–2119. 9 indexed citations

Lazarus, Jeffrey V., Camila A Picchio, John Dillon, et al.. (2019). Too many people with viral hepatitis are diagnosed late — with dire consequences. Nature Reviews Gastroenterology & Hepatology. 16(8). 451–452. 27 indexed citations

Robinson, Emma, et al.. (2019). PTU-033 Hepatitis c; pathways reaching the population other pathways can’t reach. A128.2–A129. 1 indexed citations

10.

Hajarizadeh, Behzad, Evan B. Cunningham, Heather Valerio, et al.. (2019). Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis. Journal of Hepatology. 72(4). 643–657. 114 indexed citations

11.

Radley, Andrew, Marijn de Bruin, Sarah K. Inglis, Peter T. Donnan, & John Dillon. (2018). Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial. BMJ Open. 8(12). e021443–e021443. 19 indexed citations

12.

Hellard, Margaret, Carla Treloar, Julie Bruneau, et al.. (2018). Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework. Liver International. 39(1). 20–30. 83 indexed citations

13.

Radley, Andrew, et al.. (2016). ‘Standing Outside the Junkie Door’—service users’ experiences of using community pharmacies to access treatment for opioid dependency. Journal of Public Health. 39(4). 846–855. 26 indexed citations

14.

Miller, Michael H., Kosh Agarwal, Ashley Brown, et al.. (2014). Review article: 2014 UK consensus guidelines – hepatitis C management and direct‐acting anti‐viral therapy. Alimentary Pharmacology & Therapeutics. 39(12). 1363–1375. 31 indexed citations

15.

McIntyre, Peter, et al.. (2013). 498 DRY BLOOD SPOT TESTING FOR HEPATITIS C IN PEOPLE WHO INJECTED DRUGS: REACHING THE POPULATIONS OTHER TESTS CANNOT REACH. Journal of Hepatology. 58. S204–S204. 7 indexed citations

16.

Dillon, John. (2012). Major League Baseball Team Bankruptcies: Who Wins? Who Loses?. 32(3). 297. 1 indexed citations

17.

Donnan, Peter T., David J. McLernon, John Dillon, et al.. (2009). Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE). Health Technology Assessment. 13(25). iii–iv, ix. 56 indexed citations

18.

Todd, John A., David Johnston, & John Dillon. (2000). Incidence of Barrett's oesophagus and oesophagitis at upper GI endoscopy. Gut. 46. 3 indexed citations

19.

Cosio, Fernando G., John Dillon, Michael E. Falkenhain, et al.. (1995). Racial differences in renal allograft survival: The role of systemic hypertension. Kidney International. 47(4). 1136–1141. 113 indexed citations

20.

Dillon, John. (1973). The Role of Riverine Warfare in the Civil War. Naval War College review. 26(2). 8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact